A Toronto couple is down to two options to get a dose of a $2.8-million gene therapy that could potentially save their baby's life: either raise the money themselves and buy it in the U.S. or win a dose in an international lottery run by the Swiss drugmaker.
Influx of asylum seekers reignites calls for changes to U.S. border pactRetailer stops selling unlicensed remedy made from rabid dog saliva after federal investigationTories trounce Liberals, have momentum following first-quarter fundraising raceBody found inside wall of washroom at Calgary shopping mallAmazon bringing 3,000 new tech jobs to Vancouver
0 comments:
Post a Comment